Tc99m tilmanocept is designed for the precise identification of lymph nodes that drain from a primary tumor, which have the highest probability of harboring cancer
Approval for primary and booster immunization is based on efficacy and safety data from Japan and international clinical studies
By strengthening the company's fibrotic disease development pipeline, Bridge will enhance its strategic focus on the development of comprehensive treatment solutions for idiopathic pulmonary fibrosis (IPF)
Launch of novel stent technology with 10-year safety and efficacy data adds further momentum to the company's global growth journey
New product line to address the challenge of restrictions on use of plastic straws
The data driven fertility company helps increase the success rate of fertility treatments
The facility will support clinical development by securing supply that will address the critical demand in the gene therapy and vaccine markets
India-Sweden Healthcare Innovation Centre in collaboration with AIIMS Jodhpur and AstraZeneca India launches an e-learning Upskilling Program in Diabetes Management for nurses
The HD-550 endoscopy system has been available outside of the USA since 2019
Momelotinib complements GSK’s existing expertise in haematology, with Sierra Oncology anticipating US regulatory submission in Q2 this year and EU submission in the second half of 2022
Subscribe To Our Newsletter & Stay Updated
